Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TB-LION
NCT03598842Completed
- Sponsor
- Boston Medical Center
- Start
- Jul 2019
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Open-label trial in Tuberculosis (TB) (4 arms), sponsored by Boston Medical Center. Primary endpoint: Immune response at 12 months. Started Jul 2019; status: completed.
02
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03598842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598842.